About this trial
The purpose of the study is to utilize radiomic images to precisely locate areas of tumor that can be treated with dose escalation radiation therapy.
Eligibility criteria
Qualifiers
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
For women of childbearing potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation and for an additional 52 weeks after the end of radiation.
For males of reproductive potential: use of condoms or other methods to ensure effective contraception with partner 52 weeks after radiation.
Disqualifiers
Contraindications to an MRI
Positive urine pregnancy test
Gross total excision of primary STS, including an unplanned excision
Superficial sarcoma located primarily in the subcutaneous or cutaneous tissue
Trial design
Treatments tested in this trial
- Intensity Modulated Radiation Therapy (IMRT)
- MRI
Treatment groups
Sponsors and collaborators
H. Lee Moffitt Cancer Center and Research Institute
Lead sponsor
Viewray Inc.
Collaborator